AUROPHARMA
This stock has given good breakout of double resistance trendlines along with good intensity of volumes, all other indicators are also suggesting for upside, one can go long at current levels or in dips (if any) with mentioned stop loss and targets on chart.
wave structure could be like this
key levels are mentioned on chart
breakout with good intensity of volume
chart pattern inverted head and shoulder neckline breakout
macd in weekly positive crossover and uptick
macd in daily positive and uptick
macd in hourly positive and uptick above zeroline
rsi in daily uptick and b/o
rsi in hourly above 60s and 70s
adx dmi in hourly
upper bollinger challenged in hourly
Disclaimer
I am not sebi registered analyst
My studies are for educational purpose only
Consult your financial advisor before trading or investing
I am not responsible for your profits and losses
wave structure could be like this
key levels are mentioned on chart
breakout with good intensity of volume
chart pattern inverted head and shoulder neckline breakout
macd in weekly positive crossover and uptick
macd in daily positive and uptick
macd in hourly positive and uptick above zeroline
rsi in daily uptick and b/o
rsi in hourly above 60s and 70s
adx dmi in hourly
upper bollinger challenged in hourly
Disclaimer
I am not sebi registered analyst
My studies are for educational purpose only
Consult your financial advisor before trading or investing
I am not responsible for your profits and losses
YouTube: youtube.com/@rk_charts
Telegram : t.me/RK_Charts
Twitter : @charts_rk
Email : rkcharts@gmail. com
Disclaimer.
I am not sebi registered analyst.
My studies are for educational purpose only.
Telegram : t.me/RK_Charts
Twitter : @charts_rk
Email : rkcharts@gmail. com
Disclaimer.
I am not sebi registered analyst.
My studies are for educational purpose only.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.